Xeris Pharmaceuticals Inc reported $-16042000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acelrx Pharmaceuticals ACRX:US $ -8.57M 0.86M
Acura Pharmaceuticals ACUR:US -282000 154K
Eli Lilly And LLY:US $ 3005.6M 161.6M
Endo International Ordinary Shares ENDP:US $ 226.56M 52.35M
Horizon Pharma HZNP:US $ 291.56M 100.61M
JAZZ PHA JAZZ:US $ 267.26M 90.66M
Nektar Therapeutics NKTR:US $ -111.36M 1.88M
Pacira Pharmaceuticals PCRX:US $ 41.76M 17.12M
Perrigo Ordinary Shares PRGO:US $ 92.6M 43.6M
Supernus Pharmaceuticals SUPN:US $ 23.33M 17.79M
Teva Pharmaceutical Industries TEVA:US $ 1112M 176M